Lilly Not Interested in Buying Parts of Abbott, Lechleiter Says

Eli Lilly & Co. isn’t interested in buying parts of Abbott Laboratories when it splits next year, Lilly’s chief executive officer said.

“We don’t believe large-scale combinations like that will add value for Lilly,” John Lechleiter said in a telephone interview today. “We remain focused on our strategy, which includes smaller deals and alliances.”

Before it's here, it's on the Bloomberg Terminal. LEARN MORE